Food News and Research

RSS

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

Salix Pharmaceuticals, Ltd. today announced that the Company has submitted an efficacy supplement to NDA 21-361 for XIFAXAN® (rifaximin) 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome (Non-C IBS) and IBS-related bloating.

8 Jun 2010

Boosting levels of ABCG1 protein in diabetics will improve insulin production

If you think of diabetes onset like an elaborate molecular drama, then a research team led by a La Jolla Institute scientist has unmasked a previously unknown cellular player, which is critical to proper insulin secretion. "Defective insulin secretion is a hallmark of both type 1 and type 2 diabetes," said Catherine Hedrick, Ph.D., a scientist at the La Jolla Institute for Allergy & Immunology, who led the team, which included researchers from the University of Virginia.

8 Jun 2010

CXCR4 protein may aid restore damage from MS and other neurodegenerative diseases: Researchers

A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.

8 Jun 2010

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

The Prostate Cancer Foundation announced today that researchers at the University of Michigan Comprehensive Cancer Center have discovered the RAF oncogene that drives fatal melanomas may also drive the aggressive forms of prostate cancer in the clinic.

8 Jun 2010

La Jolla Institute scientist finds protein key to insulin secretion

8 Jun 2010

APP's lyophilized Oxaliplatin for Injection receives FDA marketing approval

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today it received approval from the U.S. Food and Drug Administration to market Oxaliplatin for Injection (lyophilized), 50 mg and 100 mg.

8 Jun 2010

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque and first author of the abstract, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)," (Abstract #10004) presented in an oral session today updated positive data from PICASSO.

8 Jun 2010

Can-Fite BioPharma opens CF101 IND for psoriasis with US FDA

Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.

8 Jun 2010

Encouraging healthy lifestyle changes helps reduce aging relative's risk of cancer, say experts

Family members can help reduce an aging relative's risk of cancer by encouraging healthy lifestyle changes, according to experts at The University of Texas MD Anderson Cancer Center.

8 Jun 2010

Washington Post Q&A with Rajiv Shah; AP examines 'surging' global food prices

In light of the recent launch of USAID's "Feed the Future" initiative, the Washington Post features a Q&A with Rajiv Shah, the administrator of the agency. The interview addresses what the program will look like on the ground, the focus on female farmers and related topics (Sheridan, 6/7).

8 Jun 2010

G8 final communique draft shows agreement on maternal, child health initiative, funding amounts not yet set

A final communique draft completed last month for the upcoming G8 summit states that leaders will agree on a maternal health initiative that focuses on improving access to sexual and reproductive health services, including family planning, in the developing world, the Globe and Mail reports. The draft leaves "G8 countries free to decide whether their programs on reproductive health will fund abortions" (Clark, 6/4).

8 Jun 2010

FDA accepts Depomed's DM-1796 NDA for pain after shingles

Depomed, Inc. today announced that the New Drug Application (NDA) for DM-1796 was accepted by the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.

8 Jun 2010

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

Medtronic, Inc. announced today the launch of iPro2 Professional CGM, a continuous glucose monitoring system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth-generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications, which often go undetected with traditional A1C tests (a measurement of glucose control over a two-to-three-month period) and glucose meter measurements.

7 Jun 2010

CancerForward: The Foundation for Cancer Survivors launched

The numbers are stark. An astounding three out of every four U.S. families include one family member diagnosed with cancer. Worldwide, 28 million people - more than 12 million people in the U.S. alone - are now living with cancer. While the survivor population continues to grow, few public resources exist to promote the exchange of education and experiential information among survivors.

7 Jun 2010

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.

7 Jun 2010

Isobionics finalizes fermentation process for production of natural Valencene Pure

Isobionics has finalized the development of a breakthrough fermentation process for production of its natural Valencene Pure. This product, which is an aroma substance for the food, beverage, flavor and fragrance industry, is now available on a commercial scale. Compared with conventional valencene, which is produced from oranges, it offers the advantage of high purity and constant quality.

7 Jun 2010

NPWT clinical hotline for patients

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc announced the launch of its Negative Pressure Wound Therapy clinical hotline for patients.

7 Jun 2010

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.

7 Jun 2010

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

BioSpec Global Solutions Inc., and partner -ICBS Ltd., announced today that it has begun development of three new bio filter for the testing of E. coli, salmonella, listeria and pseudomonas in food samples. Development of the Antibody/antigen multiple discrete filters and optical system for the simultaneous analysis of E.coli, salmonella, listeria and pseudomonas in food samples.

7 Jun 2010

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.

7 Jun 2010

Food News and Research

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

Boosting levels of ABCG1 protein in diabetics will improve insulin production

CXCR4 protein may aid restore damage from MS and other neurodegenerative diseases: Researchers

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

La Jolla Institute scientist finds protein key to insulin secretion

APP's lyophilized Oxaliplatin for Injection receives FDA marketing approval

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Can-Fite BioPharma opens CF101 IND for psoriasis with US FDA

Encouraging healthy lifestyle changes helps reduce aging relative's risk of cancer, say experts

Washington Post Q&A with Rajiv Shah; AP examines 'surging' global food prices

G8 final communique draft shows agreement on maternal, child health initiative, funding amounts not yet set

FDA accepts Depomed's DM-1796 NDA for pain after shingles

Medtronic launches iPro2 Professional CGM system to help improve diabetes management

CancerForward: The Foundation for Cancer Survivors launched

Targeted therapy that benefits patients with metastatic colon cancer fails to help patients with stage III cancer

Isobionics finalizes fermentation process for production of natural Valencene Pure

NPWT clinical hotline for patients

XCell-Center GmbH announces approval of clinical trial in patients with chronic spinal cord injury

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News